American Brivision (Holding) C - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ABVC Over the counter 8731 http://www.ecologycoatings.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for American Brivision (Holding) C

American BriVision Issues Clinical Study Report for Vitargus First-in-Human Phase I Clinical Trial - Sep 9th, 2020 1:00 pm
American BriVision Announces New Patent Filed for Treatment of Major Depressive Disorder - Aug 24th, 2020 1:00 pm
American BriVision Reports Completion of ABV-1505 Phase II Part I Clinical Trial for Treatment of Adult ADHD - Jul 28th, 2020 1:00 pm
American BriVision Announces Completed Patient Enrollment in Clinical Trial at UCSF for Treatment of Adult ADHD - Jun 15th, 2020 1:00 pm
American BriVision Increases Size of Private Placement to Raise $2 Million - May 21st, 2020 1:00 pm
American BriVision Announces Two Financial Transactions to Improve Working Capital and Reduce Debt - Apr 13th, 2020 1:00 pm
American BriVision Conducts Site Monitoring Visit for Phase II Part I Clinical Trial for ABV-1505 in Adult Attention-Deficit Hyperactivity Disorder (ADHD) - Apr 6th, 2020 1:00 pm
American BriVision First Patient Enrolled for Phase II Part I Clinical Trial for ABV-1505 in Adult Attention-Deficit Hyperactivity Disorder (ADHD) - Mar 4th, 2020 2:00 pm
American BriVision Provides Corporate Update - Feb 28th, 2020 2:00 pm
American BriVision Announces Postponement of Proposed Public Offering - Feb 25th, 2020 5:57 pm
American BriVision Initiates Phase II Part I Clinical Trial for ABV-1505 in Adult Attention-Deficit Hyperactivity Disorder (ADHD) - Dec 5th, 2019 1:31 pm
American BriVision Announces Issuance of a Full Clinical Study Report (CSR) for ABV-1504 for Major Depressive Disorder Phase II Study - Nov 14th, 2019 6:22 pm
American BriVision Highlights Results from Vitargus® First-in-Human Clinical Trial - Oct 15th, 2019 7:24 pm
American BriVision Announces Vitargus® Presentation at Upcoming AAO 2019 Annual Meeting - Oct 10th, 2019 8:05 pm
American BriVision Appoints Chihliang "Andy" An as New Chief Financial Officer - Oct 8th, 2019 2:06 pm